Detecting the Disease before it’s Too Late

Abstract

Specific trials or examination exists in detecting deadly diseases. Various facilities are provided these days for determining many chronic diseases, like in detecting cancer, tuberculosis, keratin level (dialysis), coronary artery disease, etc.   But delaying in diagnosing emergency cases which need very quick action will lead to adverse situations. The process of this early detection of disease starts with a special test and further process depends on the special test result whether it is positive or negative. The sad reality of modern technology in the medical industry is that there is very less availability of vanguard doctors, who can help patients in diagnosing their disease, which can be treated successfully as soon as possible diagnosis has been done. Therefore, Hong Kong University (HKU) scientists discovered “Biomarker” which is being rapidly used by physicians, Neuroscientists and epidemiologists in measuring the intensity of disease provided with the details of its cause and treatment. Biomarkers possess possibilities in making wishes of doctors and scientists into reality, to identify that person who is at high risk of any disease so that doctors can take protective measures in saving that life within time. Nevertheless, according to Global data “Biomarkers” are a useful instrument in examining COVID-19 vaccine and fastening the process of clinical trials, decreasing the development cost and decreasing patient security risk. They also can be utilized to find the drug which can help in treating Covid-19 patients and can also be used to determine which drugs might be able to treat COVID-19 patients.